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Efﬁcacy of antivirals expressed as percentage of inhibition
ACV GCV HPMPC
Reduction of EHV3 production
after 48h
>88% >87% >58%
Reduction of plaque size 84-100% 84-92% 76-85%
Reduction of plaque number 76-96% 58-93% 13-47%
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disease, late term abortion and myelopathy. Inactivated virus
vaccines and few modiﬁed-live virus vaccines are available. A
product in Europe claiming to aid in abortion prevention has
a high antigenic load and manufacturer-speciﬁc adjuvants
(Equip®EHV-1,4; Zoetis). While few horses develop local swelling
or fever after IM administration, this is likely unacceptable for
horse owners, and could lead to decreased compliance with
vaccination. However, a post-vaccination systemic inﬂammatory
response (SIR) could also indicate a more robust speciﬁc immu-
nity. Therefore, we hypothesised that horses with detectable SIR
will have higher virus-neutralising (VN) antibody titres than
horses without detectable SIR.We also tested whether differences
exist between vaccinated mules and horses. Adult mules (n¼11)
and horses (n¼11), previously vaccinated with an inactivated
EHV-1/EHV-4 vaccine (Equip®EHV-1,4) at 6-month intervals on at
least two occasions were used. Booster vaccination was per-
formed on day 0 (d0) of the study. Before and daily post vacci-
nation for 7 days, rectal temperature, nasal discharge and
mandibular lymph node (MLN) size were recorded. Blood was
collected prior to vaccination (d0), on days 3, 5, 7, 14, 21, and
additionally when fever was detected. Serum amyloid A (SAA)
was measured on d0 e d7 as a marker of SIR. VN titres were
measured on d0, 7, 14 and 21. Normality was assessed with the
Shapiro-Wilk-test. Mann-Whitney-test was applied to compare
horses tomules. A Spearman-correlation-coefﬁcient (R2) between
the maximum increase in VN titres and the highest SAA value was
calculated. Signiﬁcance was pre-set at p<0.05. Pre-vaccination
clinical examswere all normal. A single episode of fever (>38.0C)
occurred in 4/11 (36%) horses and 2/11 (18%) mules (total fever
days per subject ¼ 1). All subjects showed seromucous nasal
discharge for 7 days. MLN were unremarkable throughout the
study. All subjects had increased post-vaccination SAA concen-
tration (>1.7mg/L) on at least one occasion. VN results (median
[interquartile range]) were signiﬁcantly different (P¼0.0058) be-
tween horses (1:256 [1:64; 1;256]) and mules (1:512 [1:256;
1:512]) on day 7. A statistically signiﬁcant (P<0.05) change in
antibody titres compared to baseline (d0) was observed in mules
on d7. No signiﬁcant difference in SAA between horses and mules
was recorded. A signiﬁcant increase in SAA was observed on d3
(P<0.001) and d5 (P<0.01) compared to d0 in both groups. No
correlation was observed between peak SAA and the increase in
VN titres in horses (R2¼0.09, CI:-0.58-0.65; P¼0.80) or mules
(R2¼0.06, CI:-0.55-0.67; P¼0.86). In conclusion, vaccination
induced SIR characterised by signiﬁcantly increased SAA, but the
intensity of SIR was not associated with a higher VN antibody
response. The immune response differed between groups, with
higher antibody production in mules. Overall, the absence of a
signiﬁcant post-vaccination rise in VN titres suggests that the
adequacy of current vaccination programs should be further in-
vestigated.
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Liege, BelgiumEquine Coital Exanthema (ECE) is an infectious, venereally
transmittedmucocutaneous disease of mares and stallions caused
by equid herpesvirus 3 (EHV3). Prevention in stallions is based on
segregating affected mares from reproduction. However, reac-
tivated virus from latently infected mares is re-excreted subclin-
ically, and therefore the prevention approach previously
described does not eliminate the risk of contagion. Outbreaks of
ECE have a negative impact on horse reproductive practices; there
is thus an urgent need of a speciﬁc method of treatment and
prevention. In previous studies, we demonstrated the efﬁcacy of
antiviral compounds, such as acyclovir (ACV), ganciclovir (GCV)
and cidofovir (HPMPC), against EHV3 reference strain. The aim of
the present work was to evaluate these compounds against
different ﬁeld isolates of EHV3 in vitro. Six EHV3 isolates were
obtained from affected mares in Argentina from 2007 and 2008.
They were selected according to phenotypic and genetic differ-
ences determined prior to this study in order to form a group of
viruses representative of the variety of the circulating EHV3.
Monolayers of EDerm cells in 12- wells tissue culture plates were
infected with 30 plaque forming units/well of each ﬁeld strain.
After two h. of incubation, overlay medium, with and without
carboxymethyl cellulose (CMC) 0.75%, supplemented with ACV 5
mg/ml, GCV 0.05 mg/ml and HPMPC 2 mg/ml was added. The two
sets of plaques were incubated at 37C in a CO2 incubator for 72 h.
The same experiment with each viral isolate but without the
addition of antiviral compound was performed as control. To
quantify EHV3 production, aliquots of the supernatant (without
CMC) were taken at 48 and 72 h after infection, and DNA was
extracted and analyzed by a quantitative real time PCR (qPCR)
targeting the gG gene. To determine plaque size and plaque
number, the cells with CMC 0.75% were ﬁxed and stained after 72
h with 0.1% formalin-buffered crystal violet solution. Results
shown in the following table are the mean value of the three
independent experiments.
In conclusion, the susceptibility of EHV3 ﬁeld isolates to ACV, GCV
and HPMPC was similar among them, and the results are in
concordance with the ones obtained with the reference EHV3
strain. The antiviral effect of these compounds was similar for
plaque size, but for plaque number and EHV3 production, HPMPC
was the least effective, being ACV and GCV similar regarding their
effectiveness against EHV3. However, as GCV was the most efﬁ-
cient compound, it will be considered to be evaluated topically on
experimentally infected mares.
068
Survey of equine herpesviruses-1, -2, -4 and -5 in 407
horses with and without respiratory disease
C.M. El-Hage*, Z.M. Mekuria, C.A. Hartley, J.R. Gilkerson
Centre for Equine Infectious Diseases, Faculty of Veterinary and
Agricultural Sciences, The University of Melbourne, Parkville
3010, Australia
Equine herpesviruses (EHVs) are common respiratory pathogens
in horses and other equids, which are responsible for serious
health, welfare and ﬁnancial consequences worldwide. The
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S66eS71 S69clinical importance of the gammaherpesviruses in horses remains
undetermined. This study aimed to determine the prevalence,
and any association between equine respiratory herpesviruses
EHV1, -2, -4 and -5 infection in horses with and without clinical
signs of respiratory disease. Cases were those horses that were
presented for exclusion of equine inﬂuenza virus (EIV) that
exhibited signs of respiratory disease including pyrexia, nasal
discharge, and/or coughing during the 2007 Australian EIV
outbreak. Nasal swabs were taken from 407 horses in Victoria,
which remained free of EIV and included clinically normal horses
that had been screened for regulatory purposes. Samples were
placed in viral transport media and subsequently stored at -80C.
Quantitative PCR was performed using primers speciﬁc for EHV1,
-4, -2 and -5. A multiplex Taqman assay was performed with
labelled probes for the alphaherpesviruses EHV-1 and -4. Sepa-
rate individual assays for the gammaherpesviruses EHV-2 and -5
were also performed. Of the three horses detected shedding EHV-
1, and the ﬁve shedding EHV-4 only onewas noted to have clinical
signs referable to respiratory disease. The proportion of EHV5
infected horses in the diseased group (85/120, 70.8%) was
signiﬁcantly greater than those not showing signs of disease (137/
249, 55%). The odds of EHV-5 positive horses demonstrating
clinical signs of respiratory disease were twice that of EHV-5
negative horses (OR 1.99, 95% CI 1.25 to 3.16). Horses infectedwith
EHV-2 made up a smaller proportion in the diseased group (18/
120, 15.0%) compared to those without disease (61/249,
24.5%,P¼0.042). The odds of disease in EHV-2 positive horses
were approximately half that in EHV-2 negative horses (OR 0.54,
95%CI 0.31 to 0.97) Fifty of the 83 horses (60.2%) shedding EHV-2
were also shedding EHV5, however there was no greater likeli-
hood of EHV5 detection in these horses compared to those
without detectable EHV-2 (199/324, 61.4%; P¼0.90). The dual
infected horses were nomore likely to exhibit signs of disease (14/
46, 30.4%) than those shedding EHV-2 alone (4/33, 12.1%;
P¼0.063) or EHV-5 alone (71/176, 40.3%; P¼0.24). Logistic
regression showed no interaction between EHV-2 and -5 shed-
ding on clinical signs of respiratory disease (P¼0.41). No quanti-
tative difference between mean loads of EHV shedding between
diseased and non-diseased horses was able to be detected. The
clinical signiﬁcance of respiratory gammaherpesvirus infections
in horses remains to be determined, however this survey adds to
the mounting body of evidence associating EHV5 with equine
respiratory disease.Acknowledgements
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Belgium, ZAVENTEM, BelgiumHorses are usually infected during the ﬁrst months of life by
several equine herpesviruses, such as EHV-1, EHV-4 or EHV-2. The
persistence of these respiratory viruses through establishment of
latency, often characterised by an absence of clinical signs, rep-
resents a real risk to the horse population. Reactivation of latent
EHV could cause disease in both carriers and naive animals in
contact. A better understanding of the immune response to EHV
infection is necessary to improve our methods of prevention and
decrease the risk of transmission. The objectives of this study
were 1/ to characterise the cytokine gene expression proﬁle of
PBMC after in vitro EHV infection (EHV-1, EHV-4 and EHV-2) and
2/ To determine the efﬁcacy of the inactivated Parapoxvirus ovis
(iPPVO), a known immunomodulator in horses , against these
same viruses. PBMC were isolated from 3 horses and infected in
vitro with EHV-1, EHV-4 or EHV-2, in the presence or absence of
iPPVO. In vitro culture of PBMC with EHV-1, EHV-4, EHV-2 and
iPPVO induced a signiﬁcant increase of IFN-a, IFN-b and IFN-g
gene expression. Moreover, EHV-2 induced a signiﬁcant increase
of IL-1b, IL-6 and TNF-amRNA. The presence of iPPVO induced an
earlier and stronger expression of IFN-a, IFN-b and IFN-g during
EHV infection. The presence of iPPVO reduced also the inﬂam-
matory response induced by EHV-2. In conclusion, this study
suggests that the presence of iPPVO potentiates the development
of the immune response during infection EHV in vitro.
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In virology, different conventional methods are commonly used
for virus titration and infectivity studies. Most of them are based
on direct examination of viral cytopathic effect, which is time
consuming, tedious and requires an endpoint reading. The RTCA
xCELLigence system (ACEA Biosciences) has been developed to
follow cellular events and their dynamics in real time using a
micro-electrical biosensor technology. The aim of this study was
to evaluate the feasibility of using this biosensor technology to
measure the effect of different equid herpesviruses on equine
dermal cell cultures, with or without antiviral acyclovir treat-
ment. Cells were infected with EHV-1 (VR700), EHV-4 (VR2230),
EHV-2 (VR701) or EHV-3 (VR352). The viral effects were moni-
tored by 3 different methods: impedance measurements (RTCA),
cytopathic effects recording (microscopy) and viral load quanti-
ﬁcation (qPCR). The RTCA technology showed a dose dependent
drop of the cellular index induced by speciﬁc impedance varia-
tions measured during growth of each virus tested. These results
correlated with the cytopathic effect induced by the different
herpesvirus species, as well as viral loads measured by qPCR. For
example, after 3 days of incubation with EHV-1, RTCA results
showed an increase of the cellular index from 0% (infection
